- Report
- August 2025
- 195 Pages
Global
From €3268EUR$3,545USD£2,753GBP
€3631EUR$3,939USD£3,059GBP
- Report
- May 2025
- 114 Pages
Global
From €4378EUR$4,750USD£3,688GBP
- Report
- October 2023
- 117 Pages
Global
From €4148EUR$4,500USD£3,494GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2765EUR$3,000USD£2,329GBP
- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2765EUR$3,000USD£2,329GBP
- Report
- June 2025
- 400 Pages
Global
From €4562EUR$4,949USD£3,843GBP
- Report
- May 2023
- 147 Pages
Global
From €4562EUR$4,949USD£3,843GBP
- Report
- April 2023
- 147 Pages
Global
From €4562EUR$4,949USD£3,843GBP
- Report
- January 2025
- 146 Pages
Global
From €3641EUR$3,950USD£3,067GBP
- Report
- September 2025
- 270 Pages
Global
From €4604EUR$4,995USD£3,878GBP
- Report
- September 2025
- 280 Pages
Global
From €4604EUR$4,995USD£3,878GBP
- Report
- June 2024
- 250 Pages
Global
From €4604EUR$4,995USD£3,878GBP
- Report
- February 2024
- 177 Pages
Global
€4604EUR$4,995USD£3,878GBP
- Report
- July 2023
- 80 Pages
United Kingdom
From €1383EUR$1,500USD£1,165GBP
From €1383EUR$1,500USD£1,165GBP
- Report
- July 2023
- 80 Pages
Saudi Arabia
From €1383EUR$1,500USD£1,165GBP
- Report
- July 2023
- 80 Pages
India
From €1383EUR$1,500USD£1,165GBP
- Report
- July 2023
- 255 Pages
Global
From €2304EUR$2,500USD£1,941GBP
- Report
- October 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,454GBP
€3641EUR$3,950USD£3,067GBP
- Report
- May 2025
- 133 Pages
Global
From €4470EUR$4,850USD£3,766GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more